This subtype of breast cancer is defined by the lack of estrogen receptor (ER), progesterone receptor, or HER2/neu expression and is unresponsive to anti-ER or human epidermal growth factor receptor 2 (HER2) targeting agents. The gene discussed is ESR1; the disease is breast cancer.